EpiBiologics

About EpiBiologics

EpiBiologics is a company focused on advancing bispecific antibodies designed to selectively degrade disease-causing extracellular proteins. Their mission is to transform people's lives by creating new therapeutic options through pioneering science, targeting challenging medical problems in areas like cancer and autoimmune disorders.

Products & Services

EpiTAC Platform:A platform leveraging a novel atlas of over 270 degradation-inducing protein receptors to create tissue-selective therapies against membrane and extracellular proteins, aiming to degrade disease-causing proteins while sparing healthy tissue.

c-Met Degrading Bispecific Antibody:A therapeutic antibody targeting c-Met for NSCLC and other c-Met driven tumors, as part of their innovative degradation approach.

Specialties

Bispecific Antibodies Protein Degradation Extracellular Protein Targeting Cancer Therapies Autoimmune Disorder Treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 23000000 MR: - FA: 23 million FAN: 23000000	D: 2023-07-20 FD: 2023-07-20	3 investors
2	RT: Series A T: - FT: Series A	A: 50000000 MR: - FA: 50 million FAN: 50000000	D: 2023-03-22 FD: 2023-03-22	4 investors

Series A Latest

2023-07-20

$23.0M

3 investors (Pro only)

Series A 2023-03-22

$50.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Ann Lee-Karlon

Chief Executive Officer and President

S

Shyra Gardai

Chief Scientific Officer

E

Eric Humke

Chief Medical Officer

A

Aaron Mishel

Chief Financial Officer

C

Craig Lichtenstein

Chief Operating Officer

J

Jennifer Cygan

Chief Business Officer (interim)

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

EpiBiologics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised